Literature DB >> 28186215

In vivo aggregation-induced transition between T1 and T2 relaxations of magnetic ultra-small iron oxide nanoparticles in tumor microenvironment.

Huige Zhou1, Jinglong Tang1, Jiayang Li1, Wanqi Li1, Ying Liu1, Chunying Chen1.   

Abstract

Surface ligands and their densities may significantly influence the optic, electric, and stable properties of inorganic nanoparticles as well as their magnetic resonance imaging (MRI) characters. In this study, ultra-small iron oxide nanoparticles with hyaluronic acid as surface ligand (Fe3O4@HA) were designed to target tumor cells and tune the T1- and T2-weighted MRI by aggregating in the tumor microenvironment via the degradation of HA upon exposure to hyaluronidase (HAase) with decreasing pH. To realize this purpose, four kinds of Fe3O4@HA nanoparticles with increasing HA density were synthesized and characterized. Fe3O4@HA280, with higher r1 value than others, was chosen for the signal modulation test in vitro; the T2 signal was enhanced by 36%, and the T1 signal decreased by 22% in the presence of HAase and acidic environment during the measurement. However, the chitosan-coated Fe3O4 nanoparticles did not show a similar tendency. The overlapping sections in the signal change graph of MDA-MB-231 cells and tumor-bearing mice also validate the self-assembling ability of Fe3O4@HA280. Meanwhile, the tumor mapping graphs indicate the excellent tumor penetration of Fe3O4@HA280, which facilitates this self-assembly process and enhances the interior section contrast of the tumor. This fundamental technique for tuning magnetic properties by the tumor microenvironment may provide a useful strategy for the rational synthesis of other inorganic nanoparticles in the field of tumor diagnostics and therapy.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28186215     DOI: 10.1039/c7nr00089h

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  7 in total

Review 1.  Nanomagnet-facilitated pharmaco-compatibility for cancer diagnostics: Underlying risks and the emergence of ultrasmall nanomagnets.

Authors:  Divya S Parimi; Yamini Gupta; Sreekar Marpu; Chandra S Bhatt; Tharun K Bollu; Anil K Suresh
Journal:  J Pharm Anal       Date:  2021-11-10

2.  One-Step Preparation of Highly Stable Copper-Zinc Ferrite Nanoparticles in Water Suitable for MRI Thermometry.

Authors:  Dorota Lachowicz; John Stroud; Janusz H Hankiewicz; River Gassen; Angelika Kmita; Joanna Stepień; Zbigniew Celinski; Marcin Sikora; Jan Zukrowski; Marta Gajewska; Marek Przybylski
Journal:  Chem Mater       Date:  2022-04-20       Impact factor: 10.508

Review 3.  The Renal Clearable Magnetic Resonance Imaging Contrast Agents: State of the Art and Recent Advances.

Authors:  Xiaodong Li; Yanhong Sun; Lina Ma; Guifeng Liu; Zhenxin Wang
Journal:  Molecules       Date:  2020-11-01       Impact factor: 4.411

4.  The effect of size and surface ligands of iron oxide nanoparticles on blood compatibility.

Authors:  Tao Liu; Ru Bai; Huige Zhou; Rongqi Wang; Jing Liu; Yuliang Zhao; Chunying Chen
Journal:  RSC Adv       Date:  2020-02-21       Impact factor: 4.036

5.  Hyaluronic Acid-Functionalized Gadolinium Oxide Nanoparticles for Magnetic Resonance Imaging-Guided Radiotherapy of Tumors.

Authors:  Chaoyang Wu; Rong Cai; Tian Zhao; Lin Wu; Lirong Zhang; Jie Jin; Lixia Xu; Pengfei Li; Tao Li; Miaomiao Zhang; Fengyi Du
Journal:  Nanoscale Res Lett       Date:  2020-04-25       Impact factor: 4.703

Review 6.  Design of Magnetic Nanoplatforms for Cancer Theranostics.

Authors:  Wangbo Jiao; Tingbin Zhang; Mingli Peng; Jiabao Yi; Yuan He; Haiming Fan
Journal:  Biosensors (Basel)       Date:  2022-01-12

7.  Magnetic, biocompatible FeCO3 nanoparticles for T2-weighted magnetic resonance imaging of in vivo lung tumors.

Authors:  Suresh Thangudu; Chun-Chieh Yu; Chin-Lai Lee; Min-Chiao Liao; Chia-Hao Su
Journal:  J Nanobiotechnology       Date:  2022-03-25       Impact factor: 10.435

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.